drugset / Trial / NCT02181920

Metamizol for the Treatment of Neoplastic Chronic Pain

NCT02181920

Phase 4 Terminated 6 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

Study to evaluate the efficacy of metamizole in reducing morphine requirements in patients with moderate to severe chronic cancer pain in comparison to administration of placebo or diclofenac.

Timeline

Start
2000-03
Primary completion
2000-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified
Subject Metamizole Unknown

Indications

No indication recorded.